Terms: = Leukemia AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
487 results:
1. Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children.
Zhang N; Li H; Wang D; Wang Z; Zhu JS; Chen K; Jiang H; Shao JB; Cai C
Clin Epigenetics; 2024 May; 16(1):63. PubMed ID: 38725010
[TBL] [Abstract] [Full Text] [Related]
2. On the mechanism of wogonin against acute monocytic leukemia using network pharmacology and experimental validation.
Wang X; Wang Y; Chen J; Wang Q; Liu Z; Yin Y; Yang T; Shen T; Sa Y
Sci Rep; 2024 May; 14(1):10114. PubMed ID: 38698063
[TBL] [Abstract] [Full Text] [Related]
3. GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy.
Liu Y; Liu Y; Chen P; Chen G; Chen X
Ann Hematol; 2024 Jun; 103(6):1967-1977. PubMed ID: 38676765
[TBL] [Abstract] [Full Text] [Related]
4. Optical genomic mapping is a helpful tool for detecting ccnd1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
[TBL] [Abstract] [Full Text] [Related]
5. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.
Knauft J; Schenk T; Ernst T; Schnetzke U; Hochhaus A; La Rosée P; Birndt S
Leukemia; 2024 Feb; 38(2):235-249. PubMed ID: 38238443
[TBL] [Abstract] [Full Text] [Related]
6. [Comprehensive Diagnosis of Mantle Cell Lymphoma].
Yang H; Guo R; Shi Y; Wang R; Qiao C; Wu YJ; Fan L; Xu W; Li JY; Qiu HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1720-1725. PubMed ID: 38071051
[TBL] [Abstract] [Full Text] [Related]
7. A conserved ZFX/WNT3 axis modulates the growth and imatinib response of chronic myeloid leukemia stem/progenitor cells.
Zhang X; Wang Y; Lu J; Xiao L; Chen H; Li Q; Li YY; Xu P; Ruan C; Zhou H; Zhao Y
Cell Mol Biol Lett; 2023 Oct; 28(1):83. PubMed ID: 37864206
[TBL] [Abstract] [Full Text] [Related]
8. [Mechanism of Proliferation and Apoptosis of Acute Promyelocytic leukemia Cell Line NB4 Induced by TPA].
Zhao P; Zhang C; Dong XM; Yan LW; Mi LY; Li YJ; Kang JC; Wang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1296-1302. PubMed ID: 37846675
[TBL] [Abstract] [Full Text] [Related]
9. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
[TBL] [Abstract] [Full Text] [Related]
10. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
[TBL] [Abstract] [Full Text] [Related]
11. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
12. CircPLXNB2 regulates acute myeloid leukemia progression through miR-654-3p/
Wang J; Wu C; Zhou W
Hematology; 2023 Dec; 28(1):2220522. PubMed ID: 37272581
[TBL] [Abstract] [Full Text] [Related]
13. Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility.
Mills GS; Chadwick V; Tang C; Perram J; Anderson MA; Anazodo A; Kidson-Gerber G; Shand A; Lavee O; Withers B; Milliken S; Di Ciaccio PR; Hamad N
Lancet Haematol; 2023 Jun; 10(6):e458-e467. PubMed ID: 37263722
[TBL] [Abstract] [Full Text] [Related]
14. Mitotic recombinatory evolution in acute leukemia.
Papenhausen P; Kelly CA; Zhang Z; Penton A
Cancer Genet; 2023 Jun; 274-275():33-40. PubMed ID: 36966725
[TBL] [Abstract] [Full Text] [Related]
15. Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.
Gupta S; Dai Y; Chen Z; Winestone LE; Teachey DT; Bona K; Aplenc R; Rabin KR; Zweidler-McKay P; Carroll AJ; Heerema NA; Gastier-Foster J; Borowitz MJ; Wood BL; Maloney KW; Mattano LA; Larsen EC; Angiolillo AL; Burke MJ; Salzer WL; Winter SS; Brown PA; Guest EM; Dunsmore KP; Kairalla JA; Winick NJ; Carroll WL; Raetz EA; Hunger SP; Loh ML; Devidas M
Lancet Haematol; 2023 Feb; 10(2):e129-e141. PubMed ID: 36725118
[TBL] [Abstract] [Full Text] [Related]
16. FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling.
Liebig S; Neumann M; Silva P; Ortiz-Tanchez J; Schulze V; Isaakidis K; Schlee C; Schroeder MP; Beder T; Morris LGT; Chan TA; Bastian L; Burmeister T; Schwartz S; Gökbuget N; Mochmann LH; Baldus CD
Sci Rep; 2023 Jan; 13(1):972. PubMed ID: 36653435
[TBL] [Abstract] [Full Text] [Related]
17. Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities.
Dorai S; Alex Anand D
Cells; 2022 Nov; 11(23):. PubMed ID: 36497125
[TBL] [Abstract] [Full Text] [Related]
18. Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors.
Kawada K; Ishida T; Jobu K; Morisawa S; Tamura N; Sugimoto S; Okazaki M; Yoshioka S; Miyamura M
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295654
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement.
Gye A; Goodall S; De Abreu Lourenco R
Pharmacoeconomics; 2023 Feb; 41(2):175-186. PubMed ID: 36266557
[TBL] [Abstract] [Full Text] [Related]
20. The Effect of Aflatoxin B1 on Tumor-Related Genes and Phenotypic Characters of MCF7 and MCF10A Cells.
Adam MAA; Kamal LZM; Kanakal M; Babu D; Dahham SS; Tabana Y; Lok B; Bermoy BM; Yunus MA; Than LTL; Barakat K; Sandai D
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233156
[TBL] [Abstract] [Full Text] [Related]
[Next]
